1. Home
  2. HUMA vs PKOH Comparison

HUMA vs PKOH Comparison

Compare HUMA & PKOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMA
  • PKOH
  • Stock Information
  • Founded
  • HUMA 2004
  • PKOH 1907
  • Country
  • HUMA United States
  • PKOH United States
  • Employees
  • HUMA N/A
  • PKOH N/A
  • Industry
  • HUMA Biotechnology: Pharmaceutical Preparations
  • PKOH Industrial Specialties
  • Sector
  • HUMA Health Care
  • PKOH Industrials
  • Exchange
  • HUMA Nasdaq
  • PKOH Nasdaq
  • Market Cap
  • HUMA 221.8M
  • PKOH N/A
  • IPO Year
  • HUMA N/A
  • PKOH N/A
  • Fundamental
  • Price
  • HUMA $1.21
  • PKOH $19.72
  • Analyst Decision
  • HUMA Strong Buy
  • PKOH
  • Analyst Count
  • HUMA 6
  • PKOH 0
  • Target Price
  • HUMA $14.60
  • PKOH N/A
  • AVG Volume (30 Days)
  • HUMA 2.9M
  • PKOH 27.3K
  • Earning Date
  • HUMA 05-20-2025
  • PKOH 05-06-2025
  • Dividend Yield
  • HUMA N/A
  • PKOH 2.51%
  • EPS Growth
  • HUMA N/A
  • PKOH 144.68
  • EPS
  • HUMA N/A
  • PKOH 2.26
  • Revenue
  • HUMA N/A
  • PKOH $1,644,000,000.00
  • Revenue This Year
  • HUMA N/A
  • PKOH $3.13
  • Revenue Next Year
  • HUMA $1,178.20
  • PKOH $3.86
  • P/E Ratio
  • HUMA N/A
  • PKOH $6.57
  • Revenue Growth
  • HUMA N/A
  • PKOH N/A
  • 52 Week Low
  • HUMA $1.15
  • PKOH $17.58
  • 52 Week High
  • HUMA $9.97
  • PKOH $34.50
  • Technical
  • Relative Strength Index (RSI)
  • HUMA 30.35
  • PKOH 46.50
  • Support Level
  • HUMA $1.35
  • PKOH $17.58
  • Resistance Level
  • HUMA $1.48
  • PKOH $21.56
  • Average True Range (ATR)
  • HUMA 0.10
  • PKOH 0.97
  • MACD
  • HUMA 0.03
  • PKOH 0.21
  • Stochastic Oscillator
  • HUMA 4.26
  • PKOH 53.64

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: